PAS
MEDP icon

Point72 Asia (Singapore)’s Medpace MEDP Stock Holding History

Point72 Asia (Singapore)’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,124
Closed -$858K – 1311
2024
Q1 		$858K Buy
2,124
+1,051
+98% +$370K 0.22% 96
2023
Q4 		$329K Buy
+1,073
New +$290K 0.08% 103

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Point72 Asia (Singapore)'s MEDP Position: Q2 2024 in Review

Point72 Asia (Singapore) sold out of Medpace (MEDP) in Q2 2024, closing a stake of 2,124 shares — an estimated $858K sold.

Point72 Asia (Singapore) first reported a position in MEDP in Q4 2023 and held it in 2 quarters. The position peaked at $858K in Q1 2024. 623 funds tracked by Wall St. Rank hold MEDP as of Q2 2024.

  • Point72 Asia (Singapore) reported no remaining Medpace position as of Q2 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 2,124 Medpace shares in Q2 2024, an estimated $858K.
  • Point72 Asia (Singapore) first reported a position in Medpace in Q4 2023 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s Medpace position peaked at $858K in Q1 2024.
  • 623 funds tracked by Wall St. Rank held Medpace as of Q2 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.